stroke: resident – brain matters module vi
DESCRIPTION
STROKE: RESIDENT – Brain Matters Module VI. 1. Acute care of ischemic stroke 2. Primary prevention 3. Secondary prevention 4. Resources for adherence to ischemic stroke guidelines. Learning objectives:. - PowerPoint PPT PresentationTRANSCRIPT
K:\STROKE CENTER\Staff Learning Opportunities\eLearn\MOD RESIDENTS (rev. 01.18.08)
1
STROKE: RESIDENT – Brain Matters
Module VI1. Acute care of ischemic stroke 2. Primary prevention3. Secondary prevention4. Resources for adherence to ischemic stroke guidelines
K:\STROKE CENTER\Staff Learning Opportunities\eLearn\MOD RESIDENTS (rev. 01.18.08)
2
1. Identify recommendations for treatment of acute ischemic stroke including t-PA and primary and secondary prevention
2. Describe MMC Stroke Service operations, rationale for focus on stroke and tools available to help providers adhere to AHA stroke care guidelines
3. Identify educational resources for stroke that will provide more in depth information
Learning objectives:
K:\STROKE CENTER\Staff Learning Opportunities\eLearn\MOD RESIDENTS (rev. 01.18.08)
3
Why should stroke be a clinical area of focus?
Nationally, stroke is the 3rd largest cause of death
Leading cause of permanent disability for the 700,000 Americans who suffer a stroke annually
MMC cares for 425+ inpatients with stroke annually
K:\STROKE CENTER\Staff Learning Opportunities\eLearn\MOD RESIDENTS (rev. 01.18.08)
4
K:\STROKE CENTER\Staff Learning Opportunities\eLearn\MOD RESIDENTS (rev. 01.18.08)
5
Primary Stroke Center criteria and certification by JCAHO
Improve awareness and availability of optimal acute stroke care
Implement secondary stroke preventionContinuous monitoring of quality
measures to improve outcomes
K:\STROKE CENTER\Staff Learning Opportunities\eLearn\MOD RESIDENTS (rev. 01.18.08)
6
Timing is critical!! The time window for treatment of patients with acute
ischemic stroke is narrow IV-Thrombolysis (t-PA) is the recommended treatment
within 3 hrs after ischemic stroke onset though benefit may be present up to 4.5 hrs Earlier therapy is associated with better outcome IV t-PA is not recommended when the time of onset
of stroke cannot be ascertained reliably Acute intracranial vessel occlusion may be treated with
intra-arterial therapy (in a 6 hr window) or Merci retrieval in selected patients
K:\STROKE CENTER\Staff Learning Opportunities\eLearn\MOD RESIDENTS (rev. 01.18.08)
7
Emergency diagnostic tests CT head to differentiate between ischemia and
hemorrhage Vascular imaging (CTA, ultrasound) for information
about the vessel patency if indicated and only IF administration of t-PA will not be delayed. If CTA indication MUST BE documented.
Evaluation of physiological parameters (HR, BP, pulse oximetry)
CBC, CMP ECG
K:\STROKE CENTER\Staff Learning Opportunities\eLearn\MOD RESIDENTS (rev. 01.18.08)
8
IV t-PA Compared with placebo, treatment with t-PA nearly
doubles the odds of recovery to independent function at 3 months after stroke and beyond
~47% of patients treated with t-PA will return to all pre-stroke physical, social and occupational functions, compared with 27% of those not treated
Rate of risk for symptomatic ICH after t-PA is 6.4%
K:\STROKE CENTER\Staff Learning Opportunities\eLearn\MOD RESIDENTS (rev. 01.18.08)
9
Question #1A 71-year-old man presents to the ED at the instruction of his PCP. This manfelt well when he went to bed at midnight but awoke at 8:00 a.m. with leftupper-extremity weakness and numbness. He called his physician who told himto go to the ED. He arrives at the ED at 9:00 a.m. The patient's PMHx includeshypertension and hyperlipidemia for which he takes a Thiazide diuretic and astatin. His BP is 178/92 mm Hg; P/E reveals mild left-sided neglect, a mild leftcentral facial palsy, mild LUE and LLE weakness, and a mild left hemi sensorydeficit. CBC, BMP are normal. CT scan of the brain is normal.
1. Which of the following is the most appropriate next step in this patient's management?
a) Start aspirin b) Start intravenous heparin c) Start clopidogrel d) Start intravenous tissue Plasminogen activator e) Lower blood pressure to 140/90 mm Hg
MKSAP 14
K:\STROKE CENTER\Staff Learning Opportunities\eLearn\MOD RESIDENTS (rev. 01.18.08)
10
Question #1: Acute treatmentAnswer: A
This patient had an acute ischemic stroke in the right MCA territory. The time of onset is unknown, but he was last known to be well at midnight, and he is therefore not eligible for intravenous thrombolytic therapy, which is indicated if therapy is started within 3 hours of onset of stroke symptoms or when the patient was last known to be well.
Early administration of aspirin, 160 to 325 mg daily, results in a modest reduction in the risk of recurrent stroke in the short term, and slightly less death and disability in the long term.
Early administration of parenteral anticoagulants has no net benefit for patients with acute stroke. Clopidogrel is not beneficial as acute stroke therapy.
Early blood pressure lowering is not recommended for most patients with acute stroke unless they are being considered for thrombolytic therapy or are suffering from a concomitant myocardial infarction or aortic dissection. In such cases, some experts aim for a target mean arterial pressure of 140 mm Hg, though without definitive evidence that this is beneficial.
MKSAP 14
K:\STROKE CENTER\Staff Learning Opportunities\eLearn\MOD RESIDENTS (rev. 01.18.08)
11
t-PA inclusion criteria:Inclusion Criteria:Clinical diagnosis of stroke Age 18 or olderTime of stroke onset (i.e. last time pt
witnessed to be well) < 3 hours BP Systolic <= 185, diastolic <= 110 (can
receive 1-3 doses of BP agent for control) Pro time <= 15 seconds or INR <= 1.7 Platelet count >= 100,000 Blood Glucose => 50 and <= 400 mg/dl
Modified from NINDS criteria
K:\STROKE CENTER\Staff Learning Opportunities\eLearn\MOD RESIDENTS (rev. 01.18.08)
12
t-PA exclusion criteria:Exclusion Criteria: Minor stroke or rapidly resolving stroke (controversial) Heparin treatment during the past 48 hours with an elevated
PTT Evidence of acute myocardial infarction Relative Contraindications: History of prior intracranial hemorrhage, neoplasm, AVM or
aneurysm Major surgical procedures within 14 days Stroke or serious head injury within 3 months Seizure at onset of stroke Gastrointestinal or urinary bleeding within last 21 days Lactation or Pregnancy within 30 days
K:\STROKE CENTER\Staff Learning Opportunities\eLearn\MOD RESIDENTS (rev. 01.18.08)
13
t-PA dose and administrationTissue Plasminogen Activator (t-PA)
Alteplase (Activase®)
Onset of action occurs in 60-90 minutes
LOADING dose = 0.09 mg/kg IV push over 1 minute (dose not to exceed 9 mg)
Followed by: INFUSION dose = 0.81 mg/kg IV infusion over 1 hour (dose
not to exceed 81 mg)tPa dose calculator and NIHS Scale are accessed through use of the ED stroke order set
K:\STROKE CENTER\Staff Learning Opportunities\eLearn\MOD RESIDENTS (rev. 01.18.08)
14
The Mainstays of Acute Treatment Treatment and stabilization of general conditions Specific therapy, either recanalization of a vessel occlusion or
prevention of mechanisms leading to neuronal death in the ischemic brain
Prophylaxis and treatment of complications Hemorrhagic transformation, space-occupying edema Seizures Aspiration Infections pressure ulcers deep vein thrombosis or pulmonary embolism
Early secondary prevention Early rehabilitation
K:\STROKE CENTER\Staff Learning Opportunities\eLearn\MOD RESIDENTS (rev. 01.18.08)
15
Acute treatment Aspirin
Small but significant reduction in death and dependency and recurrence of stroke
In a combined analysis, the reduction in death and dependency during the first 2 weeks was 1%
Anticoagulation (heparin or LMWH) Not routinely used but selected patients may benefit
K:\STROKE CENTER\Staff Learning Opportunities\eLearn\MOD RESIDENTS (rev. 01.18.08)
16
Blood Pressure Recommendations: Immediate antihypertensive therapy for moderate HTN is
recommended in case of stroke but should be applied cautiously (preservation of ischemic penumbra)
Recommended BP targets with prior HTN: 180/100-105 mmHg without prior HTN: 160-180/90-100mmHg After thrombolysis: keep BP <180/105 mmHg
Recommended drugs: IV: Labetalol, sodium nitroprusside or NTG; orally: captopril
Avoid nifedipine and any drastic BP decrease Avoid and treat hypotension particularly in unstable patients
by administering adequate amount of fluids and when required, volume expander and or catecholamine
K:\STROKE CENTER\Staff Learning Opportunities\eLearn\MOD RESIDENTS (rev. 01.18.08)
17
Acute treatment ~ Other considerations
24 hour telemetry treat fever and its cause when temp reaches 37.5◦C
Fever negatively influences neurological outcome after stroke Experimentally, fever increases infarct size
electrolyte abnormalities: rare after ischemic stroke but frequent after ICH and SAH balanced electrolyte and fluid status are important to avoid:
hypo/hypervolemia, plasma volume contraction and raised hematocrit
glucose High glucose levels in acute stroke increase the size of the
infarction and reduce functional outcome Hypoglycemia worsens outcome as well
K:\STROKE CENTER\Staff Learning Opportunities\eLearn\MOD RESIDENTS (rev. 01.18.08)
18
Other Recommendations:
● Continuous cardiac monitoring in the first 24 hrs.
● Oxygenation monitoring● O2 administration in case of hypoxemia
ABG or O2 sat <92%
K:\STROKE CENTER\Staff Learning Opportunities\eLearn\MOD RESIDENTS (rev. 01.18.08)
19
Primary PreventionPrimary Prevention
High blood pressure Atrial fibrillation Diabetes Mellitus Carotid artery disease Myocardial infarction Hormone replacement
therapy Migraine
High cholesterol Hyper-homocysteinemia Smoking Heavy alcohol use Physical
inactivity/obesity
Conditions and lifestyle factors identified as a risk for stroke:
K:\STROKE CENTER\Staff Learning Opportunities\eLearn\MOD RESIDENTS (rev. 01.18.08)
20
Primary Prevention: Atrial fibrillationAverage stroke rate in a pt with AF =
5%/year Warfarin reduces the rate by 60-70% with an
INR between 2-3 (INR <2.0 is not effective)ASA (300 mg) results in a relative risk
reduction of 21%Use CHADS score to determine need for
anticoagulationPatients with contraindications to
anticoagulant therapy should be offered ASA
K:\STROKE CENTER\Staff Learning Opportunities\eLearn\MOD RESIDENTS (rev. 01.18.08)
21
Primary Prevention: asymptomatic internal carotid (ICA) stenosisManagement is controversialPerforming carotid Endarterectomy (CEA) in
asymptomatic carotid stenosis >60% offers an absolute RR of 5.9-12.6% over 5y NNT = 8-17
In order to have benefit, the surgical risk must not exceed 3%
K:\STROKE CENTER\Staff Learning Opportunities\eLearn\MOD RESIDENTS (rev. 01.18.08)
22
Question #2A 64-year-old man is evaluated because he lost vision in the lower field of his
right eye for about 10 minutes yesterday. He wants a referral to see an ophthalmologist. His medical history includes hypertension and he is a former smoker. His medications are aspirin and enalapril. BP is 142/90 mm Hg. P/E is normal. Carotid ultrasonography reveals 70% to 80% stenosis of the right internal carotid artery and 80% to 90% stenosis of the left internal carotid artery. He has no known contraindications to carotid intervention.
2. Which of the following is the most appropriate next step in the management of this patient?
a) Right carotid Endarterectomy b) Left carotid Endarterectomy c) Switch aspirin to Warfarin d) Add clopidogrel to aspirin e) No change in therapy
MKSAP 14
K:\STROKE CENTER\Staff Learning Opportunities\eLearn\MOD RESIDENTS (rev. 01.18.08)
23
Question #2 : Secondary PreventionAnswer: A
The right internal carotid artery is stenotic and symptomatic, having caused partial transient monocular blindness (amaurosis fugax) with a typical loss of vision in either the upper or lower half of one eye. The benefit of carotid intervention is far greater for symptomatic than asymptomatic stenosis, regardless of the degree of stenosis. Carotid Endarterectomy remains the standard intervention, and is most beneficial when performed within the first few weeks after initial symptoms. Carotid angioplasty and stenting are still under investigation and are not recommended for patients who are good candidates for surgical Endarterectomy, except in the context of a randomized clinical trial.
Switching from aspirin to Warfarin has never been shown to be of benefit.
Adding clopidogrel to aspirin increases the risk of major bleeding without any additional benefit.
MKSAP 14
K:\STROKE CENTER\Staff Learning Opportunities\eLearn\MOD RESIDENTS (rev. 01.18.08)
24
Secondary Prevention ASA :13% relative risk reduction for stroke after TIA
or stroke Incidence of GI disturbances is dose dependent No difference in effectiveness amongst low
(<160mg), medium (160-325) or high (500-1500mg) dose aspirin
Dipyridamole and ASA (Aggrenox): Yields a modest risk reduction, 1% per year
Clopidogrel (Plavix): Not more effective than ASA unless patient has multiple vascular bed (CAD, PVD) disease. Combination ASA/clopidogrel for stroke indications cannot be recommended routinely
K:\STROKE CENTER\Staff Learning Opportunities\eLearn\MOD RESIDENTS (rev. 01.18.08)
25
Secondary PreventionBlood pressure, lipid, and Diabetes mellitus
control effectively reduces vascular recurrence rates in all vascular bedsKeep SBP < 140 and DBP < 90; in those
with diabetes or chronic renal disease SBP <130 and
DBP <80Keep HgbA1C <7
K:\STROKE CENTER\Staff Learning Opportunities\eLearn\MOD RESIDENTS (rev. 01.18.08)
26
(ATP) Adult Treatment Panel III Classification of:(LDL) low density lipoprotein, (HDL) high density lipoprotein cholesterol, and totalLDL-primary target of therapy ° <100 °100-129 °130-159 °160-189 °≥190
Total cholesterol °<200 ° 200-239 °≥240
HDL cholesterol °<40 °≥60
Optimal° Near/above optimal° Borderline high° High° Very high
° Desirable° Borderline high° High
° Low° High
US Dept. of Health and Human ServicesNational Institutes of HealthNational Heart, Lung and Blood Institute, 2003
K:\STROKE CENTER\Staff Learning Opportunities\eLearn\MOD RESIDENTS (rev. 01.18.08)
27
Stroke Pathways & Order SetsUse of Stroke pathways and order sets in theED and at admission aid in:1. Following specific guidelines for stroke
care in relation to hypertension control, cardiac monitoring and other parameters
2. Use of appropriate diagnostics for workup3. Streamline the process to avoid delays in t-
PA administration4. Simplify order entry and accuracy
K:\STROKE CENTER\Staff Learning Opportunities\eLearn\MOD RESIDENTS (rev. 01.18.08)
28
CEA: Secondary Prevention In pts with 70-99% carotid stenosis that is symptomatic
(specifically defined as having contributed to a TIA or minor stroke), CEA significantly reduces the 2y risk for stroke from 26% to 9%
For pts with 50-70% stenosis, the risk for stroke over 5 years decreases from 22% to 16% with surgery benefit is seen mostly in men, in those with recent stroke
symptoms, and in those with hemispheric compared with ocular symptoms
CEA is most beneficial when performed within the first 2-4 wks after the initial cerebrovascular event
Surgical risk for perioperative stroke or death must be <6% for this benefit in symptomatic carotid stenosis
no benefit for stenosis <50%.
K:\STROKE CENTER\Staff Learning Opportunities\eLearn\MOD RESIDENTS (rev. 01.18.08)
29
Available Emergency Department (ED) tools that utilize AHA guidelinesED Ischemic Stroke PathwayED Hemorrhagic Stroke (ICH/SAH)
PathwayED Transient Ischemic Attack Pathway
(TIA)The pathways are posted in trauma and CT rooms and work stations
ED Stroke Order Set
K:\STROKE CENTER\Staff Learning Opportunities\eLearn\MOD RESIDENTS (rev. 01.18.08)
30
ED PathwaysED Pathways
Can be accessed on MMC intranet Stroke Service Program
K:\STROKE CENTER\Staff Learning Opportunities\eLearn\MOD RESIDENTS (rev. 01.18.08)
31
Can be accessed on MMC intranet Stroke Service Program
K:\STROKE CENTER\Staff Learning Opportunities\eLearn\MOD RESIDENTS (rev. 01.18.08)
32
Admission Order SetsAdmission Order SetsStroke Ischemic AdultStroke Post ThrombolysisStroke-Hemorrhagic ICH / SAHStroke mini–Order (add on to other
admission order sets)TIAThese order sets incorporate AHA guidelines and quality measures, thus use is strongly encouraged to assist in the decision making process yet allowing for provider judgment. Use of order sets improves quality outcomes and streamlines the admission orders process.
K:\STROKE CENTER\Staff Learning Opportunities\eLearn\MOD RESIDENTS (rev. 01.18.08)
33
Access to order sets for stroke:
K:\STROKE CENTER\Staff Learning Opportunities\eLearn\MOD RESIDENTS (rev. 01.18.08)
34
Example of Order Set:
K:\STROKE CENTER\Staff Learning Opportunities\eLearn\MOD RESIDENTS (rev. 01.18.08)
35
Joint Commission Quality Measures(all are being monitored for compliance)
K:\STROKE CENTER\Staff Learning Opportunities\eLearn\MOD RESIDENTS (rev. 01.18.08)
36
Stroke Patient Placement:Stroke Patient Placement:Patient placement is planned with use of
designated stroke unit beds unless other factors determine otherwise
Treatment in a stroke unit has been shown to reduce death, dependence and need for long term institutional care in comparison to a general unit
Care is multidisciplinary
K:\STROKE CENTER\Staff Learning Opportunities\eLearn\MOD RESIDENTS (rev. 01.18.08)
37
K:\STROKE CENTER\Staff Learning Opportunities\eLearn\MOD RESIDENTS (rev. 01.18.08)
38
Available resources to provide Evidence-based Care
American Heart Association (AHA) Statements and Practice Guidelines for TIA, Ischemic and Hemorrhagic stroke, Atrial fibrillation
These can be found on the MMC intranet in Department section under Stroke Service Program
https://my.mmc.org/C19/C5/American%20Stroke%20Association%20Ed/default.aspxhttps://my.mmc.org/C0/C6/Maine%20Medical%20Center%20-%20In%20Hous/default.aspx
K:\STROKE CENTER\Staff Learning Opportunities\eLearn\MOD RESIDENTS (rev. 01.18.08)
39
Intranet access:Intranet access:
K:\STROKE CENTER\Staff Learning Opportunities\eLearn\MOD RESIDENTS (rev. 01.18.08)
40
Maine Medical Center Stroke Program - Operations Group
K:\STROKE CENTER\Staff Learning Opportunities\eLearn\MOD RESIDENTS (rev. 01.18.08)
41
Stroke Service Contacts:Stroke Service Contacts: Medical Director: John Belden, MD
207-883-1414 Extension 361 [email protected]
Nurse Practitioner: Georgann Dickey, RN, ANP 207-662-2069 [email protected]
Program Manager: Darcy Evans BA, BS 207-662-3406 [email protected]
We encourage input to improve stroke practice and the tools used to facilitate care.
K:\STROKE CENTER\Staff Learning Opportunities\eLearn\MOD RESIDENTS (rev. 01.18.08)
42
Intranet Stroke Education Resources: E-learns MMC library including E-books, clinical
resources and research assistance Stroke Self-study for residents:
http://www.umassmed.edu/strokestop PowerPoint presentations: Medical Grand Rounds: Stroke Dysphagia Intracranial Hemorrhage Stroke Secondary Prevention
K:\STROKE CENTER\Staff Learning Opportunities\eLearn\MOD RESIDENTS (rev. 01.18.08)
43
Post-test question(s):1. Patient inclusion criteria for fibrinolytic therapy for
acute ischemic stroke include age 18 or older, onset of symptoms less than 180 minutes before treatment would start, and
a) Stroke within previous monthb) INR< 1.7c) Serum glucose > 400 d) Blood pressure >210/120
Ans. b
K:\STROKE CENTER\Staff Learning Opportunities\eLearn\MOD RESIDENTS (rev. 01.18.08)
44
Post-test question(s):2. Which ONE of the following factors puts a 40 year
old man at the GREATEST risk of having a stroke?
a) Blood pressure of 160/95 on repeated measurementb) Body mass index of 28c) Consumption of 1 or 2 cans of beer after dinner most
nightsd) Prior history of cigarette smoking while a teenager
Ans. a
K:\STROKE CENTER\Staff Learning Opportunities\eLearn\MOD RESIDENTS (rev. 01.18.08)
45
Post-test question(s):3. To reduce the risk of pneumonia in Mrs. WO, a
stroke patient who has facial droop and dysarthria, the following is recommended:
a) Keep her N.P.O. until a swallowing evaluation has been completed by either physician or speech therapy
b) Order elevation of the head of her bed 20 degrees when providing feeding assistance
c) Discourage performing mouth care as this can make her gag
d) Recommend keeping her supine to decrease episodes of coughing
K:\STROKE CENTER\Staff Learning Opportunities\eLearn\MOD RESIDENTS (rev. 01.18.08)
46
Post-test question(s):4. The Stroke service program at MMC encourages
which of the following to promote optimal stroke care?
a) Use of specific stroke order setsb) Requesting smoking cessation counseling and/or
medications for tobacco usersc) Consider rehabilitation for all stroke patientsd) All of the above
Ans. d
K:\STROKE CENTER\Staff Learning Opportunities\eLearn\MOD RESIDENTS (rev. 01.18.08)
47